News Industry News Robocath’s Joint Venture, Cathbot, Concludes First Clinical Study in China to Evaluate Robotic PCI Safety and Efficacy July 20, 2022
News Conference News EuroPCR 2022 Long-term Outcomes With PCI and CABG: More Analyses to Stir the Pot Michael O'Riordan May 23, 2022
News Conference News SCAI 2022 DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year L.A. McKeown May 23, 2022
News Daily News The NCDR Has Made a Difference, but Experts See Room for Growth Todd Neale April 28, 2022
News Daily News Routine IVUS in Peripheral Interventions Supported by Small RCT L.A. McKeown March 09, 2022
News Conference News ISC 2022 Endovascular Stroke Therapy Works for Large Infarcts: RESCUE-Japan LIMIT Todd Neale February 09, 2022
News Industry News IMPRESSION Randomized Trial: Past the halfway mark and progressing rapidly January 22, 2022
News Daily News Discharge Safe as Early as a Day After Primary PCI for STEMI L.A. McKeown December 15, 2021
News Conference News TCT 2021 DCBs in Coronaries? Some Good News, but More Work Needed L.A. McKeown November 06, 2021
News Conference News VIVA 2021 Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI L.A. McKeown October 08, 2021
News Industry News IMPRESSION – A randomised trial to evaluate the efficacy of MagicTouch Sirolimus Coated Balloon in Dysfunctional Fistula progresses rapidly. June 24, 2021
News Daily News Stenting for Aortic Coarctation Can Have Late Complications: COAST Caitlin E. Cox June 03, 2021
News Conference News SCAI 2021 Harmony TPV Continues to Reduce Pulmonary Valve Regurgitation at 1 Year Yael L. Maxwell May 04, 2021
News Features Crude Awakening: Should Interventional Cardiology Come Clean on Dirty Talk? Shelley Wood March 22, 2021
News Daily News FDA Advisors Unconvinced by Lutonix BTK Drug-Coated Balloon L.A. McKeown February 18, 2021
News Daily News FDA Data Raise Red Flags for Suture-Based Vascular Closure Devices Caitlin E. Cox February 11, 2021
News Daily News Safe to Upgrade From Pacemaker or Defibrillator to CRT Michael O'Riordan February 10, 2021